The Ensign Group, Inc.

ENSG Healthcare Medical Care Facilities

The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.

Revenue
+14.5%
EPS
+23.6%
Free cash flow
+89.2%
Total debt
+39.2%

Quarter to September 2026, against a year earlier

181.15 1.24 −0.68%
Market cap
$10.6B
P/E
26.3×
Fwd P/E
25.4×
Dividend yield
0.14%
F-score
7/9
Altman Z
3.57
Beneish M
−2.57
Dividend safety
92/100

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
5,057.84 4,260.49 3,729.36 3,025.47 2,627.46 2,402.60 2,036.52 1,754.60 1,598.33 1,654.86
Revenue Growth
18.72% 14.24% 23.27% 15.15% 9.36% 17.98% 16.07% 9.78% (3.42%) 23.33%
Gross Profit
799.45 667.58 590.76 517.98 468.21 407.47 291.11 218.68 172.90 188.47
Operating Income
425.31 358.30 255.37 296.83 260.46 223.16 129.18 84.91 43.19 91.85
EBT
455.62 386.09 272.76 289.09 258.00 217.61 116.17 71.75 31.18 85.82
Income after Tax
344.26 298.46 209.85 224.65 197.73 171.36 92.21 59.06 16.97 52.84
Net Income Common
343.97 297.97 209.40 224.68 194.65 170.48 110.53 92.36 40.48 49.99
EPS (Diluted)
5.84 5.12 3.65 3.95 3.42 3.06 1.97 1.70 0.77 0.96
Shares (Diluted, Weighted)
58.87 58.24 57.32 56.87 56.93 55.79 55.98 54.40 52.83 52.13
Gross Margin
15.81% 15.67% 15.84% 17.12% 17.82% 16.96% 14.29% 12.46% 10.82% 11.39%
EBIT Margin
8.41% 8.41% 6.85% 9.81% 9.91% 9.29% 6.34% 4.84% 2.70% 5.55%
Net Profit Margin
6.80% 6.99% 5.61% 7.43% 7.41% 7.10% 5.43% 5.26% 2.53% 3.02%
Free Cash Flow Margin
7.33% 4.43% 7.25% 6.40% 7.91% 13.46% 6.29% 9.36% 1.76% 2.98%
EBITDA
530.69 443.50 328.82 360.22 317.31 278.57 181.32 130.29 86.07 131.35
EBIT
425.31 358.30 255.37 296.83 260.46 223.16 129.18 84.91 43.19 91.85

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 2 Nov 2026